|
41 |
Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study Enthalten in BMC pulmonary medicine Bd. 12, 11.12.2012, Nr. 1, date:12.2012: 1-8
|
|
|
42 |
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study Enthalten in BMC neurology Bd. 12, 6.3.2012, Nr. 1, date:12.2012: 1-13
|
|
|
43 |
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets Enthalten in Nature Communications Bd. 13, 15.6.2022, Nr. 1, date:12.2022: 1-15
|
|
|
44 |
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials Enthalten in BMC medicine Bd. 19, 6.12.2021, Nr. 1, date:12.2021: 1-15
|
|
|
45 |
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade Enthalten in Journal of translational medicine Bd. 22, 5.3.2024, Nr. 1, date:12.2024: 1-12
|
|
|
46 |
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers Enthalten in Communications biology Bd. 5, 6.10.2022, Nr. 1, date:12.2022: 1-15
|
|
|
47 |
“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade Enthalten in Acta neuropathologica Bd. 147, 11.12.2023, Nr. 1, date:6.2024: 1-24
|
|
|
48 |
De novo variants in the RNU4-2 snRNA cause a frequent neurodevelopmental syndrome Enthalten in Nature Bd. 632, 11.7.2024, Nr. 8026, date:8.2024: 832-840
|
|
|
49 |
Deciphering the role of histone modifications in memory and exhausted CD8 T cells Enthalten in Scientific reports Bd. 15, 19.5.2025, Nr. 1, date:12.2025: 1-22
|
|
|
50 |
Dysregulation of the epigenetic landscape of normal aging in Alzheimer’s disease Enthalten in Nature neuroscience Bd. 21, 5.3.2018, Nr. 4, date:4.2018: 497-505
|
|